Home/ Supplements/ Dim/ Diindolylmethane (DIM)

Diindolylmethane (DIM)

product on market Powder BulkSupplements.com Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 100% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · grounded in 1 source · methodology

Diindolylmethane is researched for its role in modulating estrogen metabolism and supporting hormonal balance. Current evidence supporting these specific health claims is limited, as most data comes from small-scale or preclinical studies. The ingredient maintains a high safety profile for general use.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Diindolylmethane (DIM)
Open Full PDF View on NIH DSLD →
Details

Label Data

200 Milligram(s)
Serving Size
1250
Servings
Non-Nutrient/Non-Botanical
Product Type
100%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Market median: 200.0mg (3 products) 11 studies (A:1, B:3)
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Suggested Use: As a dietary supplement, take 200 mg (about 1/10 tsp) one to two times daily, or a directed by a physician.

Warnings & Precautions

Always consult a physician before taking any dietary supplement.

Keep out of reach of children.

Formulation Notes

Free of: Sugar, soy, dairy, yeast, gluten, additives

Additional Information

Contents are sold by weight, not volume. Settling may occur. Store in a dry, cool, dark place.

Use an accurate milligram scale. New

Metadata

Product Details

UPC / SKUX0010353HR
DSLD Entry Date2024-06-20
Product TypeNon-Nutrient/Non-Botanical
FormPowder
DSLD ID312407
Data Updated2026-04-11
Research

Research Evidence

5
Research Sources
44
Avg Quality
5
Rct
C A randomized, placebo-controlled trial of diindolylmethane for breast cancer biomarker modulation in patients taking tamoxifen
Rct Breast cancer research and treatment 2017 PubMed DOI
C Phase Ib placebo-controlled, tissue biomarker trial of diindolylmethane (BR-DIMNG) in patients with prostate cancer who are undergoing prostatectomy
Rct European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) 2016 PubMed DOI
C Effectiveness of 3,3'-Diindolylmethane Supplements on Favoring the Benign Estrogen Metabolism Pathway and Decreasing Body Fat in Premenopausal Women
Rct Nutrition and cancer 2023 PubMed DOI
C The effects of light exposure on the cortisol stress response in human males.
Rct Stress (Amsterdam, Netherlands) PubMed DOI
D Pilot study: effect of 3,3'-diindolylmethane supplements on urinary hormone metabolites in postmenopausal women with a history of early-stage breast cancer
Rct Nutrition and cancer 2004 PubMed
View all evidence for Dim →
Compare

Similar Products

View all Dim products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.